Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Urolithiasis
Published in: Urolithiasis 1/2019

Open Access 01-02-2019 | Invited Review

Precision medicine in renal stone-formers

Authors: Fay Hill, John A. Sayer

Published in: Urolithiasis | Issue 1/2019

Login to get access

Abstract

Here we define precision medicine approaches and discuss how these may be applied to renal stone-formers to optimise diagnosis and a management. Using the gene discovery of monogenic stone disorders as examples, we discuss the benefits of personalising therapies for renal stone-formers to provide improved prevention and treatment of these disorders.
Literature
1.
Allison MJ, Dawson KA, Mayberry WR, Foss JG (1985) Oxalobacter formigenes gen. nov., sp. nov.: oxalate-degrading anaerobes that inhabit the gastrointestinal tract. Arch Microbiol 141:1–7CrossRefPubMed
2.
Bollee G, Cochat P, Daudon M (2015) Recurrence of crystalline nephropathy after kidney transplantation in APRT deficiency and primary hyperoxaluria. Can J Kidney Health Dis 2:31CrossRefPubMedPubMedCentral
3.
Braun DA, Lawson JA, Gee HY, Halbritter J, Shril S, Tan W, Stein D, Wassner AJ, Ferguson MA, Gucev Z, Fisher B, Spaneas L, Varner J, Sayer JA, Milosevic D, Baum M, Tasic V, Hildebrandt F (2016) Prevalence of monogenic causes in pediatric patients with nephrolithiasis or nephrocalcinosis. Clin J Am Soc Nephrol CJASN 11:664–672CrossRefPubMed
4.
Bull MJ, Plummer NT (2014) Part 1: The human gut microbiome in health and disease. Integr Med (Encinitas Calif) 13:17–22
5.
Curhan GC, Willett WC, Rimm EB, Stampfer MJ (1997) Family history and risk of kidney stones. J Am Soc Nephrol 8:1568–1573PubMed
6.
Daga A, Majmundar AJ, Braun DA, Gee HY, Lawson JA, Shril S, Jobst-Schwan T, Vivante A, Schapiro D, Tan W, Warejko JK, Widmeier E, Nelson CP, Fathy HM, Gucev Z, Soliman NA, Hashmi S, Halbritter J, Halty M, Kari JA, El-Desoky S, Ferguson MA, Somers MJG, Traum AZ, Stein DR, Daouk GH, Rodig NM, Katz A, Hanna C, Schwaderer AL, Sayer JA, Wassner AJ, Mane S, Lifton RP, Milosevic D, Tasic V, Baum MA, Hildebrandt F (2018) Whole exome sequencing frequently detects a monogenic cause in early onset nephrolithiasis and nephrocalcinosis. Kidney Int 93: 204–213CrossRefPubMed
7.
Ferraro PM, D’Addessi A, Gambaro G (2013) When to suspect a genetic disorder in a patient with renal stones, and why. Nephrol Dialysis Transpl 28:811–820CrossRef
8.
Gee HY, Jun I, Braun DA, Lawson JA, Halbritter J, Shril S, Nelson CP, Tan W, Stein D, Wassner AJ, Ferguson MA, Gucev Z, Sayer JA, Milosevic D, Baum M, Tasic V, Lee MG, Hildebrandt F (2016) Mutations in SLC26A1 cause nephrolithiasis. Am J Hum Genet 98:1228–1234CrossRefPubMedPubMedCentral
9.
Goldfarb DS, Fischer ME, Keich Y, Goldberg J (2005) A twin study of genetic and dietary influences on nephrolithiasis: a report from the Vietnam Era Twin (VET). Registry Kidney Int 67:1053–1061CrossRefPubMed
10.
11.
Guillen M, Corella D, Cabello ML, Garcia AM, Hernandez-Yago J (1999) Reference values of urinary excretion of cystine and dibasic aminoacids: classification of patients with cystinuria in the Valencian Community, Spain. Clin Biochem 32:25–30CrossRefPubMed
12.
Halbritter J, Baum M, Hynes AM, Rice SJ, Thwaites DT, Gucev ZS, Fisher B, Spaneas L, Porath JD, Braun DA, Wassner AJ, Nelson CP, Tasic V, Sayer JA, Hildebrandt F (2015) Fourteen monogenic genes account for 15% of nephrolithiasis/nephrocalcinosis. J Am Soc Nephrol 26:543–551CrossRefPubMed
13.
Hopp K, Cogal AG, Bergstralh EJ, Seide BM, Olson JB, Meek AM, Lieske JC, Milliner DS, Harris PC (2015) Phenotype-genotype correlations and estimated carrier frequencies of primary hyperoxaluria. J Am Soc Nephrol 26:2559–2570CrossRefPubMedPubMedCentral
14.
Hoppe B, Niaudet P, Salomon R, Harambat J, Hulton SA, Van’t Hoff W, Moochhala SH, Deschenes G, Lindner E, Sjogren A, Cochat P (2017) A randomised Phase I/II trial to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria. Pediatr Nephrol (Berlin, Germany) 32:781–790CrossRef
15.
Hsi RS, Sanford T, Goldfarb DS, Stoller ML (2017) The role of the 24-hour urine collection in the prevention of kidney stone recurrence. J Urol 197:1084–1089CrossRefPubMed
16.
Letavernier E, Kauffenstein G, Huguet L, Navasiolava N, Bouderlique E, Tang E, Delaitre L, Bazin D, de Frutos M, Gay C, Perez J, Verpont MC, Haymann JP, Pomozi V, Zoll J, Le Saux O, Daudon M, Leftheriotis G, Martin L (2018) ABCC6 deficiency promotes development of randall plaque. J Am Soc Nephrol 29:2337–2347CrossRefPubMed
17.
Ljunghall S, Danielson BG, Fellstrom B, Holmgren K, Johansson G, Wikstrom B (1985) Family history of renal stones in recurrent stone patients. Br J Urol 57:370–374CrossRefPubMed
18.
McCloskey S, Yates LM, Sayer JA (2016) The importance of taking a family history in the nephrology clinic. Br J Renal Med 21:38–42
19.
Moochhala SH (2012) Extracellular pyrophosphate in the kidney: how does it get there and what does it do? Nephron Physiol 120:33–38CrossRef
20.
Moochhala SH, Sayer JA, Carr G, Simmons NL (2008) Renal calcium stones: insights from the control of bone mineralization. Exp Physiol 93:43–49CrossRefPubMed
21.
Parks JH, Coward M, Coe FL (1997) Correspondence between stone composition and urine supersaturation in nephrolithiasis. Kidney Int 51:894–900CrossRefPubMed
22.
23.
Policastro LJ, Saggi SJ, Goldfarb DS, Weiss JP (2018) Personalized intervention in monogenic stone formers. J Urol 199:623–632CrossRefPubMed
24.
Rhodes HL, Yarram-Smith L, Rice SJ, Tabaksert A, Edwards N, Hartley A, Woodward MN, Smithson SL, Tomson C, Welsh GI, Williams M, Thwaites DT, Sayer JA, Coward RJ (2015) Clinical and genetic analysis of patients with cystinuria in the United Kingdom. Clin J Am Soc Nephrol CJASN 10:1235–1245CrossRefPubMed
25.
Rice SJ, Thwaites DT, Halbritter J, Sayer JA (2014) Cystinuria revisited: presentations with calcium-containing stones demands vigilance and screening in the stone clinic. Med Surg Urol 3:140
26.
Runolfsdottir HL, Palsson R, Agustsdottir IM, Indridason OS, Edvardsson VO (2016) Kidney disease in adenine phosphoribosyltransferase deficiency. Am J Kidney Dis 67:431–438CrossRefPubMed
27.
28.
Sayer JA (2017) Progress in understanding the genetics of calcium-containing nephrolithiasis. J Am Soc Nephrol 28:748–759CrossRefPubMed
29.
Scheinman SJ, Cox JP, Lloyd SE, Pearce SH, Salenger PV, Hoopes RR, Bushinsky DA, Wrong O, Asplin JR, Langman CB, Norden AG, Thakker RV (2000) Isolated hypercalciuria with mutation in CLCN5: relevance to idiopathic hypercalciuria. Kidney Int 57:232–239CrossRefPubMed
30.
Stern JM, Moazami S, Qiu Y, Kurland I, Chen Z, Agalliu I, Burk R, Davies KP (2016) Evidence for a distinct gut microbiome in kidney stone formers compared to non-stone formers Urolithiasis 44: 399–407CrossRefPubMed
31.
Ticinesi A, Milani C, Guerra A, Allegri F, Lauretani F, Nouvenne A, Mancabelli L, Lugli GA, Turroni F, Duranti S, Mangifesta M, Viappiani A, Ferrario C, Dodi R, Dall’Asta M, Del Rio D, Ventura M, Meschi T (2018) Understanding the gut-kidney axis in nephrolithiasis: an analysis of the gut microbiota composition and functionality of stone formers. Gut 67:2097–2106CrossRefPubMed
32.
Toka HR, Genovese G, Mount DB, Pollak MR, Curhan GC (2013) Frequency of rare allelic variation in candidate genes among individuals with low and high urinary calcium excretion. PloS One 8:e71885CrossRefPubMedPubMedCentral
33.
Vasudevan V, Samson P, Smith AD, Okeke Z (2017) The genetic framework for development of nephrolithiasis. Asian J Urol 4:18–26CrossRefPubMed
Metadata
Title
Precision medicine in renal stone-formers
Authors
Fay Hill
John A. Sayer
Publication date
01-02-2019
Publisher
Springer Berlin Heidelberg
Published in
Urolithiasis / Issue 1/2019
Print ISSN: 2194-7228
Electronic ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-018-1091-5

Other articles of this Issue 1/2019

Urolithiasis 1/2019 Go to the issue

Invited Review

Cystinuria: genetic aspects, mouse models, and a new approach to therapy

Invited Review

Calcium-sensing receptor: evidence and hypothesis for its role in nephrolithiasis

Invited Review

Empiric therapy for kidney stones

Preface

Empirical therapy or precision medicine for kidney stone formers in the ‘-omics’ era?

Invited Review

Nephrolithiasis secondary to inherited defects in the thick ascending loop of henle and connecting tubules

Invited Review

Inherited proximal tubular disorders and nephrolithiasis